These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14575940)

  • 1. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants.
    Stefanick ML; Cochrane BB; Hsia J; Barad DH; Liu JH; Johnson SR
    Ann Epidemiol; 2003 Oct; 13(9 Suppl):S78-86. PubMed ID: 14575940
    [No Abstract]   [Full Text] [Related]  

  • 2. The Women's Health Initiative recruitment methods and results.
    Hays J; Hunt JR; Hubbell FA; Anderson GL; Limacher M; Allen C; Rossouw JE
    Ann Epidemiol; 2003 Oct; 13(9 Suppl):S18-77. PubMed ID: 14575939
    [No Abstract]   [Full Text] [Related]  

  • 3. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures.
    Langer RD; White E; Lewis CE; Kotchen JM; Hendrix SL; Trevisan M
    Ann Epidemiol; 2003 Oct; 13(9 Suppl):S107-21. PubMed ID: 14575943
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementation of the Women's Health Initiative study design.
    Anderson GL; Manson J; Wallace R; Lund B; Hall D; Davis S; Shumaker S; Wang CY; Stein E; Prentice RL
    Ann Epidemiol; 2003 Oct; 13(9 Suppl):S5-17. PubMed ID: 14575938
    [No Abstract]   [Full Text] [Related]  

  • 5. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants.
    Ritenbaugh C; Patterson RE; Chlebowski RT; Caan B; Fels-Tinker L; Howard B; Ockene J
    Ann Epidemiol; 2003 Oct; 13(9 Suppl):S87-97. PubMed ID: 14575941
    [No Abstract]   [Full Text] [Related]  

  • 6. The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants.
    Jackson RD; LaCroix AZ; Cauley JA; McGowan J
    Ann Epidemiol; 2003 Oct; 13(9 Suppl):S98-106. PubMed ID: 14575942
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone replacement therapy: a time for pause.
    Yusuf S; Anand S
    CMAJ; 2002 Aug; 167(4):357-9. PubMed ID: 12197690
    [No Abstract]   [Full Text] [Related]  

  • 8. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.
    van der Mooren MJ; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):123-4. PubMed ID: 12648855
    [No Abstract]   [Full Text] [Related]  

  • 10. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rashomon revisited: two views of monitoring the Women's Health Initiative trials.
    Goodman SN
    Clin Trials; 2007; 4(3):205-6. PubMed ID: 17715245
    [No Abstract]   [Full Text] [Related]  

  • 12. Negative Women's Health Initiative findings stir consternation, debate among researchers.
    Twombly R
    J Natl Cancer Inst; 2006 Apr; 98(8):508-10. PubMed ID: 16622115
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S
    Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational studies, clinical trials, and the women's health initiative.
    Prentice RL
    Lifetime Data Anal; 2007 Dec; 13(4):449-62. PubMed ID: 17943443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone replacement therapy after the Women's Health Initiative.
    Doty TJ
    JAAPA; 2005 Jan; 18(1):30-7; quiz 39-40. PubMed ID: 15675117
    [No Abstract]   [Full Text] [Related]  

  • 16. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ; Ma J; Stafford RS
    Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
    Derry PS
    Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled RCTs: In postmenopausal women, hormone therapy for 6 to 7 years did not affect mortality at 18 years.
    Johnson BE; Johnson CA
    Ann Intern Med; 2018 Jan; 168(2):JC4. PubMed ID: 29335716
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of media coverage of Women's Health Initiative study on attitudes and behavior of women receiving hormone replacement therapy.
    McIntosh J; Blalock SJ
    Am J Health Syst Pharm; 2005 Jan; 62(1):69-74. PubMed ID: 15658075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.